Quest Diagnostics Inc. (DGX)

103.73
0.21 0.20
NYSE : Health Services
Prev Close 103.52
Open 103.53
Day Low/High 103.14 / 104.25
52 Wk Low/High 78.95 / 107.97
Volume 388.23K
Avg Volume 945.00K
Exchange NYSE
Shares Outstanding 134.67M
Market Cap 13.87B
EPS 5.40
P/E Ratio 19.96
Div & Yield 2.12 (2.02%)

Latest News

Quest Diagnostics And Hc1 Collaborate To Optimize Enterprise-wide Laboratory Testing For Health Systems

Quest Diagnostics And Hc1 Collaborate To Optimize Enterprise-wide Laboratory Testing For Health Systems

Strategic collaboration aims to improve patient care and reduce costs across thousands of health systems nationwide by delivering insights that empower optimal lab testing

Workforce Drug Positivity Increases In More Than One-Third Of U.S. Industry Sectors Examined, According To Quest Diagnostics Multi-Year Analysis

Workforce Drug Positivity Increases In More Than One-Third Of U.S. Industry Sectors Examined, According To Quest Diagnostics Multi-Year Analysis

Retail industry tops list with highest overall positivity rate for four consecutive years

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J.

Quest Diagnostics Shares Surge After Healthy Quarterly Results

Quest Diagnostics Shares Surge After Healthy Quarterly Results

Quest earned $1.73 a share, beating the $1.68 consensus estimate. Volume growth helped offset "significant reimbursement pressures."

Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon

Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon

Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.

Quest Diagnostics Reports Second Quarter 2019 Financial Results

Quest Diagnostics Reports Second Quarter 2019 Financial Results

- Second quarter revenues of $1.95 billion, up 1.8% from 2018

Quest Diagnostics Welcomes New Members To The Global Diagnostics Network (GDN)

Quest Diagnostics Welcomes New Members To The Global Diagnostics Network (GDN)

Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers

Sharecare Names Quest Diagnostics Its Preferred Laboratory Partner To Advance Digital Health Management

Sharecare Names Quest Diagnostics Its Preferred Laboratory Partner To Advance Digital Health Management

ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management...

Employer Wellness Screening With Digital Diabetes Prevention Program May Lower Eight-Year Risk Of Diabetes, Suggests Quest Diagnostics Study

Employer Wellness Screening With Digital Diabetes Prevention Program May Lower Eight-Year Risk Of Diabetes, Suggests Quest Diagnostics Study

Participants decreased diabetes risk by 2.8 percent on average and 31 percent lost five percent or more of body weight after completing at least nine lessons in program

Faruqi & Faruqi, LLP Is Investigating Quest Diagnostics Incorporated (DGX) On Behalf Of Its Shareholders

Faruqi & Faruqi, LLP Is Investigating Quest Diagnostics Incorporated (DGX) On Behalf Of Its Shareholders

NEW YORK, June 6, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Quest Diagnostics Incorporated ("Quest Diagnostics" or the "Company") (NYSE:DGX).

Quest Diagnostics Now Participating In NCI-MATCH Precision Medicine Clinical Trial

Quest Diagnostics Now Participating In NCI-MATCH Precision Medicine Clinical Trial

As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J.

Quest Diagnostics Climbs on First-Quarter Earnings Beat

Quest Diagnostics Climbs on First-Quarter Earnings Beat

Quest Diagnostics climbs after beating first-quarter earnings expectations.

Quest Diagnostics Reports First Quarter 2019 Financial Results

Quest Diagnostics Reports First Quarter 2019 Financial Results

- First quarter revenues of $1.89 billion, up 0.4% from 2018

Quest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™

Quest Diagnostics Launches New Consumer-Initiated STD Tests Through QuestDirect™

Available nationwide, the new services link consumer-initiated testing with medical oversight and counsel to help combat the nation's record rate of STDs

Quest Diagnostics Becomes #151 Most Shorted S&P 500 Component, Replacing American International Group

Quest Diagnostics Becomes #151 Most Shorted S&P 500 Component, Replacing American International Group

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Quest Diagnostics Expected to Earn $1.37 a Share

Quest Diagnostics Expected to Earn $1.37 a Share

Revenue expected to fall 3% to $1.9 billion for medical services provider.

TheStreet Quant Rating: B+ (Buy)